Insider txns (12m)
0
Stock / equity
FTGC First Trust Global Tactical Commodity Strategy Fun
- Security
- Equity
- Members of Congress
- 1
- Latest trade on record
- June 25, 2026
FTGC (First Trust Global Tactical Commodity Strategy Fun) has 0 disclosed insider transactions from 0 insiders in the last 12 months (0 open-market buys, 0 sales, about $0 at reported prices) and 6 congressional trades from 1 member of Congress. The most recent disclosure was filed August 24, 2026.
Open-market buys / sales
0 / 0
Congress trades (12m)
6
Distinct filers (12m)
1
Share price
Price and chart by TradingView for First Trust Global Tactical Commodity Strategy Fun. US share prices here are delayed, not real-time. The trade records on this page come from government filings, not from this chart.
FTGC in charts
Who is trading this stock
Which people account for the buying and selling over the last 12 months?
BoughtSold
1 person accounts for the disclosed buying and selling in FTGC over the last 12 months; the most active is Rep. John Boozman with $75K.
Members of Congress trading FTGC
Members whose periodic transaction reports name this ticker. Amounts are the sums of the ranges as filed.
| Member | Seat | Trades | Bought | Sold | Range as filed | Latest |
|---|---|---|---|---|---|---|
| John Boozman | Senator (AR), Republican | 6 | 3 | 3 | $6,006–$90K | June 25, 2026 |
Insider transactions
No Form 4 transactions for this ticker in the tracked window yet.
Congressional trades
| Filer | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| John Boozman | Sell | November 21, 2025 | August 24, 2026 | — | — | — | $1,001–$15K | joint | Senate PTR ↗ | |
| John Boozman | Sell | June 25, 2026 | July 13, 2026 | 18d | — | — | $1,001–$15K | joint | Senate PTR ↗ | |
| John Boozman | Sell | May 27, 2026 | June 16, 2026 | — | — | — | $1,001–$15K | joint | Senate PTR ↗ | |
| John Boozman | Buy | March 19, 2026 | April 14, 2026 | 26d | — | — | $1,001–$15K | joint | Senate PTR ↗ | |
| John Boozman | Buy | January 23, 2026 | February 15, 2026 | 23d | — | — | $1,001–$15K | joint | Senate PTR ↗ | |
| John Boozman | Buy | October 3, 2025 | November 15, 2025 | 43d | — | — | $1,001–$15K | joint | Senate PTR ↗ |
Related stocks
Tickers traded by the same people who traded FTGC, by number of filers in common. It shows overlap in public filings and nothing else.
- UBER Uber Technologies, Inc. Common Stock 1 filer in common
- ANET Arista Networks, Inc. Common Stock 1 filer in common
- META Meta Platforms, Inc. - Class A Common Stock 1 filer in common
- MU Micron Technology, Inc. - Common Stock 1 filer in common
- NFLX Netflix, Inc. - Common Stock 1 filer in common
- ADBE Adobe Inc. - Common Stock 1 filer in common
- CRM Salesforce, Inc. Common Stock 1 filer in common
- LLY Eli Lilly and Company Common Stock 1 filer in common
Guides for this page
- How to read a congressional trade report Owner tells you whose asset it was: the member, the spouse, a dependent child, or held jointly.
- Why congressional trade amounts are ranges There are ten ranges; the lowest is $1,001–$15,000 and the highest is over $50,000,000.
- What disclosure data cannot tell you Filings are late by design: up to 45 days for Congress, two business days for insiders.
Sources and method
| Source | Filings | Rows | First filed | Newest filed | Read the originals |
|---|---|---|---|---|---|
| Senate eFD, periodic transaction reports | 6 | 6 | November 15, 2025 | August 24, 2026 | Senate eFD search |
Site built October 27, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.
Insider rows are Form 4 filings for this issuer from SEC EDGAR; congressional rows are periodic transaction reports parsed from the House Clerk and the Senate eFD. Values use the reported price for Form 4 and the disclosed range for Congress. See methodology and corrections.
Not investment advice. Disclosures are shown as filed and may lag the trade or be amended. No recommendation is made or implied.